Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
11 studies found for:    antibiotic | "Alzheimer Disease"
Show Display Options
Rank Status Study
1 Completed MRI to Measure Treatment With Antibiotics in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention:
2 Unknown  A Pilot Study of Inflammatory Markers in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: doxycycline;   Drug: rifampin;   Drug: placebo
3 Unknown  Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid
Condition: Alzheimer's Disease
Interventions: Drug: doxycycline;   Drug: rifampicin;   Drug: Placebo matched to doxycycline;   Drug: Placebo matched to Rifampin
4 Completed Drug-Drug Interaction Study With Rifampin
Condition: Alzheimer Disease
Interventions: Drug: BMS-708163;   Drug: Rifampin
5 Completed
Has Results
Minocycline in Patients With Alzheimer's Disease
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease
Intervention: Drug: Minocycline
6 Unknown  Thalidomide for Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Thalidomide
7 Completed Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects
Condition: Alzheimer Disease
Interventions: Drug: BMS-708163;   Drug: Placebo;   Drug: Moxifloxacin
8 Completed Study Evaluating the Effect of Lecozotan SR on the QTc Interval
Conditions: Alzheimer Disease;   Healthy
Interventions: Drug: Lecozotan SR;   Drug: Moxifloxacin
9 Withdrawn QTc Study of Rosi XR in Healthy Volunteers
Condition: Alzheimer's Disease
Interventions: Drug: Rosi XR;   Other: Placebo;   Drug: Moxifloxacin
10 Completed AZD3293 Thorough QT Study in Healthy Male Volunteers
Condition: Alzheimer's Disease
Interventions: Drug: AZD3293;   Drug: Placebo;   Drug: Moxifloxacin
11 Completed A Study to Assess Effects of Clarithromycin on Pharmacokinetics of JNJ-54861911 in Healthy Male Participants
Condition: Healthy
Interventions: Drug: JNJ-54861911, 25 mg;   Drug: Itraconazole 200 mg;   Drug: Clarithromycin 500 mg

Indicates status has not been verified in more than two years